GB2013084B - Ophthalmic drug dosage - Google Patents

Ophthalmic drug dosage

Info

Publication number
GB2013084B
GB2013084B GB7845835A GB7845835A GB2013084B GB 2013084 B GB2013084 B GB 2013084B GB 7845835 A GB7845835 A GB 7845835A GB 7845835 A GB7845835 A GB 7845835A GB 2013084 B GB2013084 B GB 2013084B
Authority
GB
United Kingdom
Prior art keywords
drug dosage
ophthalmic drug
ophthalmic
dosage
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7845835A
Other languages
English (en)
Other versions
GB2013084A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of GB2013084A publication Critical patent/GB2013084A/en
Application granted granted Critical
Publication of GB2013084B publication Critical patent/GB2013084B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB7845835A 1978-01-25 1978-11-23 Ophthalmic drug dosage Expired GB2013084B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87207478A 1978-01-25 1978-01-25

Publications (2)

Publication Number Publication Date
GB2013084A GB2013084A (en) 1979-08-08
GB2013084B true GB2013084B (en) 1982-07-28

Family

ID=25358780

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7845835A Expired GB2013084B (en) 1978-01-25 1978-11-23 Ophthalmic drug dosage

Country Status (7)

Country Link
JP (2) JPS6059885B2 (fr)
CA (1) CA1108053A (fr)
CH (1) CH640737A5 (fr)
DE (1) DE2902863C2 (fr)
FR (1) FR2415459A1 (fr)
GB (1) GB2013084B (fr)
MX (1) MX6520E (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347238A (en) 1979-10-26 1982-08-31 Smith & Nephew Associated Companies Limited Autoclavable emulsion containing silver sulphadiazine

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US6255299B1 (en) 1985-01-07 2001-07-03 Leo Pharmaceutical Products Ltd. Opthalmic gel composition and method of treating eye infections
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
CN1049358C (zh) * 1993-01-01 2000-02-16 参天制药株式会社 含羧酸乙烯聚合物的滴眼剂及其制造方法
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
DE69523044T2 (de) 1994-03-04 2002-06-20 Univ Washington Seattle Block- und pfropfcopolymere und dazu gehöriges verfahren
US5683709A (en) * 1994-05-05 1997-11-04 Ciba Vision Corporation Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
MXPA02003731A (es) 1999-10-15 2003-12-11 Leo Pharm Prod Ltd Derivados novedosos de acido fusidico.
DK1654002T4 (da) * 2003-08-07 2014-02-17 Allergan Inc Sammensætninger til fremføring af terapeutiske midler til øjnene
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1012060A (en) * 1964-10-06 1977-06-14 Gilman N. Cyr Dimethyl sulfoxide gel preparations
FR2038105A1 (fr) * 1969-04-01 1971-01-08 Syntex Corp Composition anti-inflammatoire locale et son mode d'utilisation
DK135267A (fr) * 1971-02-25
DE2239206A1 (de) * 1971-08-12 1973-03-15 Hydrophilics Int Inc Copolymer
US3957740A (en) * 1972-04-24 1976-05-18 Hydrophilics International, Inc. Copolymers
FR2191941A1 (en) * 1972-07-10 1974-02-08 Serabonian Giacomo Gelatinising water-sol and aq liqs - by addn of carboxypolymer and alginic acid salt
DE2265164C3 (de) * 1972-10-18 1985-08-22 Vsesojuznyj naučno-issledovatel'skij i ispytatel'nyj institut medicinskoj techniki, Moskau/Moskva Verwendung von Acrylsäureamidcopolymeren zur Herstellung von Grundlagen für ophthalmologische Arzneiformen
AR206692A1 (es) * 1972-12-27 1976-08-13 Alza Corp Agente dispensador de liberacion sostenida de substancias activas
LU70487A1 (fr) * 1974-07-08 1976-05-31
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
IL50250A (en) * 1975-08-27 1980-01-31 Hydrophilics Int Inc Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347238A (en) 1979-10-26 1982-08-31 Smith & Nephew Associated Companies Limited Autoclavable emulsion containing silver sulphadiazine

Also Published As

Publication number Publication date
FR2415459B1 (fr) 1983-03-18
CA1108053A (fr) 1981-09-01
FR2415459A1 (fr) 1979-08-24
CH640737A5 (de) 1984-01-31
JPS6059885B2 (ja) 1985-12-27
DE2902863C2 (de) 1994-02-24
JPS54110312A (en) 1979-08-29
JPH0428244B2 (fr) 1992-05-13
JPS62215518A (ja) 1987-09-22
DE2902863A1 (de) 1979-07-26
MX6520E (es) 1985-06-27
GB2013084A (en) 1979-08-08

Similar Documents

Publication Publication Date Title
US4295567B1 (en) Medicament container
JPS567714A (en) Pharmaceutical medicine
GB2085732B (en) Administration set
AU513845B2 (en) Pharmaceutical dosage forms
IL58209A0 (en) Medicament inhaler
IL58303A0 (en) Removable drug implant
AU521053B2 (en) Medicament dosage form
JPS55147223A (en) Pharmaceutical medicine
GB2013084B (en) Ophthalmic drug dosage
ZA796549B (en) New pharmaceutical preparations
ZA787000B (en) Pharmaceutical formulation
GB2020655B (en) Pharmaceutical compounds
JPS54157817A (en) Pharmaceutical prepared solution
JPS54132563A (en) Corticosteroid antiiinflammatry drug
ZA793923B (en) Medicinal formulation
JPS54141797A (en) Therapeutic drug
JPS5524175A (en) Agricultural drug
JPS54135795A (en) Diuretic drug
GB2039739B (en) Medicament against glaucoma
JPS5527168A (en) Drug composition
JPS5519257A (en) Medicine retard form
ZA793928B (en) Medicinal formulation
JPS5555114A (en) Fine drug
GB2028660B (en) Administration set
RO77521A2 (fr) Medicament antirhumatismal

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 19981122